Trials / Completed
CompletedNCT05560841
Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis
Prospective, " Evaluator Blinded " Clinical Investigation to Evaluate the Effectiveness and Safety of Nailner Brush 2-in-1 in the Treatment of Onychomycosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Karo Pharma AB · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the effectiveness of Nailner Brush 2-in-1 in the treatment of onychomycosis based on the blinded evaluation of the percentage of healthy nail surface after 6 months of treatment compared to baseline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | topical treatment | Topical application of Nailner brush 2in1 for toenail onychomycosis |
Timeline
- Start date
- 2022-07-28
- Primary completion
- 2023-01-12
- Completion
- 2023-04-10
- First posted
- 2022-09-29
- Last updated
- 2023-10-04
Locations
2 sites across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT05560841. Inclusion in this directory is not an endorsement.